Willow Biosciences Inc. (WLLW.TO) trades at C$0.035 after hours on 20 Feb 2026, following a sharp volume spike that flags an oversold bounce setup. The share price sits well below the 50-day average C$0.14 and 200-day average C$0.25, creating a technical gap that short-term traders may target. WLLW.TO stock shows active interest with volume 3,804,082 versus average 144,583, raising odds of a mean-reversion move in the near term.
WLLW.TO stock technical snapshot
The immediate technical picture shows price at C$0.035 and a day range between C$0.03 and C$0.035, highlighting a very narrow trading band after hours. The stock is trading far below its moving averages, with 50-day C$0.14 and 200-day C$0.25, a classic oversold profile that can produce short rallies when volume expands.
Advertisement
Volume, liquidity and trade flow
Volume today hit 3,804,082 versus an average of 144,583, giving a relative volume of 26.31x and confirming strong trading interest. High relative volume on a low-priced stock can fuel quick bounces but also wide intraday swings, so liquidity-driven moves matter more than fundamentals for short-term entries.
Fundamentals and valuation
On fundamentals, Willow Biosciences reports EPS -0.16 and a trailing PE of -0.22, reflecting losses. Key balance-sheet metrics include cash per share C$1.15 and book value per share C$1.13, while market cap sits at C$5,151,895.00. Price-to-book is extremely low at 0.03, but the thin market cap and share structure raise execution risk for longer-term investors.
Meyka AI grade and forecast
Meyka AI rates WLLW.TO with a score out of 100: 69.67 (Grade B) — HOLD. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month price of C$0.12, implying an upside of 242.86% from C$0.035; forecasts are model-based projections and not guarantees.
Risks, sector context and catalysts
WLLW.TO operates in the Healthcare sector and the specialty drug makers industry, where sector trends are mixed and liquidity matters. Key risks include thin market cap, volatile trading, and negative margins. Near-term catalysts that could drive a bounce include positive contract wins, licensing updates, or improved revenue guidance.
Trading strategy for an oversold bounce
For an oversold bounce approach, use a tight risk plan: consider partial positions near C$0.03–C$0.04, stop-loss below C$0.025, and a short-term profit target between C$0.08 and C$0.14. Monitor volume and news flow closely and avoid large size given the stock’s volatility and small market cap.
Final Thoughts
WLLW.TO stock shows a textbook oversold bounce setup after hours on 20 Feb 2026. Price at C$0.035 sits well below moving averages and book value, while volume 3,804,082 signals active participation that can lift the share price in a short window. Our Meyka AI grade is 69.67 (B, HOLD) and the model projects C$0.12 in 12 months, a 242.86% implied upside from the current price; this projection is model-based and not a guarantee. Traders seeking an oversold bounce should size positions small, use a clear stop-loss near C$0.025, and watch for company updates or sector moves in healthcare. For investors focused on fundamentals, the company’s reported cash per share C$1.15 and book value C$1.13 merit further due diligence before increasing exposure. See the latest chart and trade data on our Meyka stock page and recent market commentary on MarketBeat for context source.
Advertisement
FAQs
Is WLLW.TO stock a buy after the after-hours move?
WLLW.TO stock shows a short-term oversold bounce setup, but it carries high risk. Traders may buy small positions for a quick rebound and set strict stops. Long-term buys require deeper review of cash, revenue, and licensing.
What price targets and stops suit an oversold bounce strategy?
Use a stop near C$0.025 and short-term profit targets around C$0.08 to C$0.14. Adjust size to limit downside given the stock’s thin market cap and intraday volatility.
How reliable is Meyka AI’s forecast for WLLW.TO?
Meyka AI’s forecast model projects C$0.12 over 12 months and implies 242.86% upside from C$0.035. Forecasts are model-based projections and not guarantees; use them with other research.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Advertisement
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)